Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation

Journal of Experimental Medicine

Volumn 209, Issue 7, 2012, Pages 1309-1324

  Boulard, Olivier ^a   Kirchberger, Stefanie ^a   Royston, Daniel J ^a   Maloy, Kevin J ^b   Powrie, Fiona M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CHROMOSOME 3; COLITIS; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; GENE; GENE FUNCTION; GENE LOCUS; GRANULOCYTE; HICCS GENE; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHOID CELL; MICROSATELLITE MARKER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; AZOXYMETHANE; CARCINOGENS; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; COLITIS; COLORECTAL NEOPLASMS; DISEASE RESISTANCE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, 129 STRAIN; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; TELOMERE;

EID: 84864320130     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120239     Document Type: Article

References (58)

1. Ahmadi, A., S. Polyak, and P.V. Draganov. 2009. Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J. Gastroenterol. 15:61-66. http://dx.doi.org/10.3748/wjg.15.61
2. Anderson, C.A., G. Boucher, C.W. Lees, A. Franke, M. D'Amato, K.D. Taylor, J.C. Lee, P. Goyette, M. Imielinski, A. Latiano, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43:246-252. http://dx.doi.org/10.1038/ng.764
3. Asquith, M.J., O. Boulard, F. Powrie, and K.J. Maloy. 2010. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology. 139:519-529: 529: e1-e2. http://dx.doi.org/10.1053/j.gastro.2010.04.045
4. Balkwill, F., and L.M. Coussens. 2004. Cancer: an inflammatory link. Nature. 431:405-406. http://dx.doi.org/10.1038/431405a
5. Balkwill, F., and A. Mantovani. 2010. Cancer and inflammation: implications for pharmacology and therapeutics. Clin. Pharmacol. Ther. 87:401-406. http://dx.doi.org/10.1038/clpt.2009.312
6. Barrett, J.C., S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, J.D. Rioux, S.R. Brant, M.S. Silverberg, K.D. Taylor, M.M. Barmada, et al NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40:955-962. http://dx.doi.org/10.1038/ng.175
7. Barrett, J.C., J.C. Lee, C.W. Lees, N.J. Prescott, C.A. Anderson, A. Phillips, E. Wesley, K. Parnell, H. Zhang, H. Drummond, et al UK IBD Genetics Consortium; Wellcome Trust Case Control Consortium 2. 2009. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat. Genet. 41:1330-1334. http://dx.doi.org/10.1038/ng.483
8. Beckwith, J., Y. Cong, J.P. Sundberg, C.O. Elson, and E.H. Leiter. 2005. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology. 129:1473-1484. http://dx.doi.org/10.1053/j.gastro.2005.07.057
9. Bleich, A., G. Büchler, J. Beckwith, L.M. Petell, J.P. Affourtit, B.L. King, D.J. Shaffer, D.C. Roopenian, H.J. Hedrich, J.P. Sundberg, and E.H. Leiter. 2010. Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm. Bowel Dis. 16:765-775. http://dx.doi.org/10.1002/ibd.21146
10. Bollrath, J., T.J. Phesse, V.A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 15:91-102. http://dx.doi.org/10.1016/j.ccr.2009.01.002
11. Borm, M.E., J. He, B. Kelsall, A.S. Peña, W. Strober, and G. Bouma. 2005. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. Gastroenterology. 128:74-85. http://dx.doi.org/10.1053/j.gastro.2004.10.044
12. Buonocore, S., P.P. Ahern, H.H. Uhlig, I.I. Ivanov, D.R. Littman, K.J. Maloy, and F. Powrie. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 464:1371-1375. http://dx.doi.org/10.1038/nature08949
13. Cahill, R.J., C.J. Foltz, J.G. Fox, C.A. Dangler, F. Powrie, and D.B. Schauer. 1997. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65:3126-3131.
14. Crowe, S.E. 2005. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 21:32-38.
15. de Silva, S., S. Devlin, and R. Panaccione. 2010. Optimizing the safety of biologic therapy for IBD. Nat. Rev. Gastroenterol. Hepatol. 7:93-101. http://dx.doi.org/10.1038/nrgastro.2009.221
16. Duerr, R.H., K.D. Taylor, S.R. Brant, J.D. Rioux, M.S. Silverberg, M.J. Daly, A.H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 314:1461-1463. http://dx.doi.org/10.1126/science.1135245
17. Ea, C.K., L. Sun, J. Inoue, and Z.J. Chen. 2004. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA. 101:15318-15323. http://dx.doi.org/10.1073/pnas.0404132101
18. Eaden, J.A., K.R. Abrams, and J.F. Mayberry. 2001. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 48:526-535. http://dx.doi.org/10.1136/gut.48.4.526
19. Erdman, S.E., T. Poutahidis, M. Tomczak, A.B. Rogers, K. Cormier, B. Plank, B.H. Horwitz, and J.G. Fox. 2003a. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162:691-702. http://dx.doi.org/10.1016/S0002-9440(10)63863-1
20. Erdman, S.E., V.P. Rao, T. Poutahidis, M.M. Ihrig, Z. Ge, Y. Feng, M. Tomczak, A.B. Rogers, B.H. Horwitz, and J.G. Fox. 2003b. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63:6042-6050.
21. Erdman, S.E., V.P. Rao, T. Poutahidis, A.B. Rogers, C.L. Taylor, E.A. Jackson, Z. Ge, C.W. Lee, D.B. Schauer, G.N. Wogan, et al. 2009. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc. Natl. Acad. Sci. USA. 106:1027-1032. http://dx.doi.org/10.1073/pnas.0812347106
22. Ermann, J., W.S. Garrett, J. Kuchroo, K. Rourida, J.N. Glickman, A. Bleich, and L.H. Glimcher. 2011. Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus. Proc. Natl. Acad. Sci. USA. 108:7137-7141. http://dx.doi.org/10.1073/pnas.1104234108
23. Feagins, L.A., R.F. Souza, and S.J. Spechler. 2009. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 6:297-305. http://dx.doi.org/10.1038/nrgastro.2009.44
24. Garrett, W.S., S. Punit, C.A. Gallini, M. Michaud, D. Zhang, K.S. Sigrist, G.M. Lord, J.N. Glickman, and L.H. Glimcher. 2009. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell. 16:208-219. http://dx.doi.org/10.1016/j.ccr.2009.07.015
25. Garrett, W.S., C.A. Gallini, T. Yatsunenko, M. Michaud, A. DuBois, M.L. Delaney, S. Punit, M. Karlsson, L. Bry, J.N. Glickman, et al. 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 8:292-300. http://dx.doi.org/10.1016/j.chom.2010.08.004
26. Garrity-Park, M.M., E.V. Loftus Jr., W.J. Sandborn, S.C. Bryant, and T.C. Smyrk. 2009. MHC Class II alleles in ulcerative colitis-associated colorectal cancer. Gut. 58:1226-1233. http://dx.doi.org/10.1136/gut.2008.166686
27. Ge, Z., D.A. White, M.T. Whary, and J.G. Fox. 2001. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus. J. Clin. Microbiol. 39:2598-2602. http://dx.doi.org/10.1128/JCM.39.7.2598-2602.2001
28. Ge, Z., A.B. Rogers, Y. Feng, A. Lee, S. Xu, N.S. Taylor, and J.G. Fox. 2007. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 9:2070-2080. http://dx.doi.org/10.1111/j.1462-5822.2007.00939.x
29. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15:103-113. http://dx.doi.org/10.1016/j.ccr.2009.01.001
30. Guerra, L., A. Albihn, S. Tronnersjö, Q. Yan, R. Guidi, B. Stenerlöw, T. Sterzenbach, C. Josenhans, J.G. Fox, D.B. Schauer, et al. 2010. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS ONE. 5:e8924. http://dx.doi.org/10.1371/journal.pone.0008924
31. Hampe, J., A. Franke, P. Rosenstiel, A. Till, M. Teuber, K. Huse, M. Albrecht, G. Mayr, F.M. De La Vega, J. Briggs, et al. 2007. A genomewide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39:207-211. http://dx.doi.org/10.1038/ng1954
32. Hatakeyama, M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer. 4:688-694. http://dx.doi.org/10.1038/nrc1433
33. Heine, M., C.I. Cramm-Behrens, A. Ansari, H.P. Chu, A.G. Ryazanov, H.Y. Naim, and R. Jacob. 2005. Alpha-kinase 1, a new component in apical protein transport. J. Biol. Chem. 280:25637-25643. http://dx.doi.org/10.1074/jbc.M502265200
34. Houlston, R.S., E. Webb, P. Broderick, A.M. Pittman, M.C. Di Bernardo, S. Lubbe, I. Chandler, J. Vijayakrishnan, K. Sullivan, S. Penegar, et al Colorectal Cancer Association Study Consortium; CoRGI Consortium; International Colorectal Cancer Genetic Association Consortium. 2008. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet. 40:1426-1435. http://dx.doi.org/10.1038/ng.262
35. Hue, S., P. Ahern, S. Buonocore, M.C. Kullberg, D.J. Cua, B.S. McKenzie, F. Powrie, and K.J. Maloy. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473-2483. http://dx.doi.org/10.1084/jem.20061099
36. Hugot, J.P., M. Chamaillard, H. Zouali, S. Lesage, J.P. Cézard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:599-603. http://dx.doi.org/10.1038/35079107
37. Izcue, A., S. Hue, S. Buonocore, C.V. Arancibia-Cárcamo, P.P. Ahern, Y. Iwakura, K.J. Maloy, and F. Powrie. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 28:559-570. http://dx.doi.org/10.1016/j.immuni.2008.02.019
38. Kanneganti, M., M. Mino-Kenudson, and E. Mizoguchi. 2011. Animal models of colitis-associated carcinogenesis. J. Biomed. Biotechnol. 2011: 342637. http://dx.doi.org/10.1155/2011/342637
39. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature. 441:431-436. http://dx.doi.org/10.1038/nature04870
40. Khor, B., A. Gardet, and R.J. Xavier. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature. 474:307-317. http://dx.doi.org/10.1038/nature10209
41. Kullberg, M.C., J.M. Ward, P.L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic, and A. Sher. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66:5157-5166.
42. Kullberg, M.C., D. Jankovic, C.G. Feng, S. Hue, P.L. Gorelick, B.S. McKenzie, D.J. Cua, F. Powrie, A.W. Cheever, K.J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485-2494. http://dx.doi.org/10.1084/jem.20061082
43. Maloy, K.J., L. Salaun, R. Cahill, G. Dougan, N.J. Saunders, and F. Powrie. 2003. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-119. http://dx.doi.org/10.1084/jem.20021345
44. Manolio, T.A., F.S. Collins, N.J. Cox, D.B. Goldstein, L.A. Hindorff, D.J. Hunter, M.I. McCarthy, E.M. Ramos, L.R. Cardon, A. Chakravarti, et al. 2009. Finding the missing heritability of complex diseases. Nature. 461:747-753. http://dx.doi.org/10.1038/nature08494
45. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancerrelated inflammation. Nature. 454:436-444. http://dx.doi.org/10.1038/nature07205
46. Markel, P., P. Shu, C. Ebeling, G.A. Carlson, D.L. Nagle, J.S. Smutko, and K.J. Moore. 1997. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat. Genet. 17:280-284. http://dx.doi.org/10.1038/ng1197-280
47. Nagamine, C.M., A.B. Rogers, J.G. Fox, and D.B. Schauer. 2008. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int. J. Cancer. 122:832-838. http://dx.doi.org/10.1002/ijc.23175
48. Ogura, Y., D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R.H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:603-606. http://dx.doi.org/10.1038/35079114
49. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45
50. Popivanova, B.K., K. Kitamura, Y. Wu, T. Kondo, T. Kagaya, S. Kaneko, M. Oshima, C. Fujii, and N. Mukaida. 2008. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118:560-570.
51. Saleh, M., and G. Trinchieri. 2011. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat. Rev. Immunol. 11:9-20. http://dx.doi.org/10.1038/nri2891
52. Sobin, L.H., and C. Wittekind. 1997. UICC TNM classification of malignant tumors [5th edition]. Wiley-Liss, New York. 227 pp.
53. Thompson, A.I., and C.W. Lees. 2011. Genetics of ulcerative colitis. Inflamm. Bowel Dis. 17:831-848. http://dx.doi.org/10.1002/ibd.21375
54. Ullman, T.A., and S.H. Itzkowitz. 2011. Intestinal inflammation and cancer. Gastroenterology. 140:1807-1816. http://dx.doi.org/10.1053/j.gastro.2011.01.057
55. Uronis, J.M., M. Mühlbauer, H.H. Herfarth, T.C. Rubinas, G.S. Jones, and C. Jobin. 2009. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE. 4:e6026. http://dx.doi.org/10.1371/journal.pone.0006026
56. Wang, S.J., H.P. Tu, A.M. Ko, S.L. Chiang, S.J. Chiou, S.S. Lee, Y.S. Tsai, C.P. Lee, and Y.C. Ko. 2011. Lymphocyte α-kinase is a goutsusceptible gene involved in monosodium urate monohydrate-induced inflammatory responses. J. Mol. Med. 89:1241-1251. http://dx.doi.org/10.1007/s00109-011-0796-5
57. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 447:661-678. http://dx.doi.org/10.1038/nature05911
58. Wu, S., K.J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H.R. Yen, D.L. Huso, F.L. Brancati, E. Wick, F. McAllister, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15:1016-1022. http://dx.doi.org/10.1038/nm.2015